Texas House of Representatives Human Services Committee to Host Public Hearing

Translate to Spanish or other 102 languages!

The public hearing will take place at the Edinburg Conference Center at Renaissance on August 29, 2018

Mega Doctor News

- Advertisement -

Edinburg, Texas ― The Texas House of Representatives Human Services Committee will host a public hearing at the Edinburg Conference Center at Renaissance in Edinburg, TX, on August 29, 2018, at 8:30 a.m. During the hearing members will review the history and future roll-out of Medicaid Managed Care in Texas. Members will examine the impact managed care has had on the quality and cost of health care throughout the state, and review initiatives that managed care organizations have implemented to improve the quality and care. Members will also investigate:

Whether access to care and if network adequacy contractual requirements are sufficient;
Provider and Medicaid participants’ satisfaction within STAR, STAR Health, Star Kids, and STAR+Plus managed care programs; and
The Health and Human Services Commission’s (HHSC) oversight of managed care organizations to make recommendations for any needed improvement.
Notice of Assistance at Public Meetings

Persons with disabilities who plan to attend this meeting and who may need assistance, such as a sign language interpreter, are requested to contact Stacey Nicchio at (512) 463-0850, 72 hours prior to the meeting so that appropriate arrangements can be made.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.
- Advertisement -